Olmesartan Medoxomil, An Angiotensin II-Receptor Blocker, Ameliorates Renal Injury In db/db Mice

BACKGROUND: Diabetic nephropathy (DN) is a common complication of diabetes mellitus (DM) and also a major cause of end-stage renal disease (ESRD). Olmesartan medoxomil (OM) is an angiotensin II receptor blocker (ARB) and has been shown to exhibit renoprotective effects on a streptozotocin (STZ)-indu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Ye, Li, Ze-Liang, Ding, Ao, Yang, Hui, Zhu, Wei-Ping, Cui, Tong-Xia, Zhang, Hui-Tao, Zhang, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815789/
https://www.ncbi.nlm.nih.gov/pubmed/31695333
http://dx.doi.org/10.2147/DDDT.S217826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815789/
https://www.ncbi.nlm.nih.gov/pubmed/31695333
http://dx.doi.org/10.2147/DDDT.S217826

Ejemplares similares